NCT00278174已完成2 期
A Phase II Trial of Interferon Alpha-1b (IFN Alpha-1b) in Patients With Metastatic Clear Cell Renal Carcinoma
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 7
- 试验地点
- 2
- 主要终点
- Safety
研究概览
简要总结
RATIONALE: Interferon alfa may interfere with the growth of tumor cells and slow the growth of kidney cancer.
PURPOSE: This phase II trial is studying how well interferon alfa works in treating patients with metastatic kidney cancer.
详细描述
OBJECTIVES:
Primary
- Determine the objective response rate in patients with metastatic renal clear cell carcinoma treated with interferon alfa-1b.
Secondary
- Determine the toxicity of this drug in these patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Safety
Efficacy
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney CancerKidney CancerNCT00002737European Organisation for Research and Treatment of Cancer - EORTC320
已完成
2 期
Interferon Alfa in Treating Children With HIV-Related CancerUnspecified Childhood Solid Tumor, Protocol SpecificLymphomaLeukemiaNCT00002621Children's Oncology Group8
已完成
1 期
Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or MyelomaKidney CancerUnspecified Adult Solid Tumor, Protocol SpecificBreast CancerMultiple MyelomaLymphomaMelanomaSarcomaNCT00276536The Cleveland Clinic35
已完成
3 期
Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney CancerKidney CancerNCT00053820Medical Research Council670
已完成
3 期
Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)Kidney CancerNCT00072046Alliance for Clinical Trials in Oncology732